Results 91 to 100 of about 20,877 (202)

Double-blind clonazepam vs placebo in panic disorder treatment [PDF]

open access: yesArquivos de Neuro-Psiquiatria, 2000
OBJECTIVE: To assess the effectiveness of clonazepam, in a fixed dose (2 mg/day), compared with placebo in the treatment of panic disorder patients. METHOD: 24 panic disorder patients with agoraphobia were randomly selected.
ALEXANDRE MARTINS VALENÇA   +5 more
doaj  

NKX2‐1 Downstream Regulatory Structural Variants Explain a Substantial Proportion of Molecular Diagnoses in Patients With Benign Hereditary Chorea

open access: yesMovement Disorders, EarlyView.
Abstract Background NKX2‐1–related disorders (NKX2‐1‐RDs) classically present with a triad of neurological, endocrine, and pulmonary manifestations, including benign hereditary chorea. However, in a fraction of patients, NKX2‐1 coding variants are not detected, and variants outside the NKX2‐1 locus have been reported.
Robin Wijngaard   +33 more
wiley   +1 more source

Polypharmacy among adolescents and adults with cerebral palsy in a clinical setting

open access: yesPM&R, EarlyView.
Abstract Background Adolescents and adults with cerebral palsy often experience multimorbidity related to their condition, which primarily affects movement and posture but is also associated with pain, epilepsy, mood disorders, and other conditions. As such, these patients are often prescribed a range of medications to manage symptoms, thereby putting ...
Caitlin Cassidy   +3 more
wiley   +1 more source

Correlation Between Hyperbaric Oxygen Therapy Course and Reduction of Clonazepam in Patients with Paroxysmal Sympathetic Hyperactivity: A Retrospective Cohort Study

open access: yesXiehe Yixue Zazhi
ObjectiveTo analyze the correlation between the duration of hyperbaric oxygen (HBO) therapy and oral medication clonazepam reduction in patients with paroxysmal sympathetic hyperactivity (PSH).MethodsClinical data of patients with secondary PSH after ...
LIU Sujuan   +4 more
doaj   +1 more source

ANÁLISE DO CLONAZEPAM EM AMOSTRAS DE MEDICAMENTOS REFERÊNCIA E GENÉRICOS POR ESPECTROSCOPIA NO INFRAVERMELHO (FTIR-ATR)

open access: yesRevista UniVap, 2017
O Clonazepam é um benzodiazepínico de ação antiansiolítica, anticonvulsiva, relaxante muscular, sedativa e possui propriedades hipnóticas. Seu uso deve ser somente a critério médico.
Fabrisia de Moraes Alves da Silva   +1 more
doaj   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

open access: yesAddiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka   +6 more
wiley   +1 more source

Carbon dioxide induced panic attacks and short term clonazepam treatment: preliminary study [PDF]

open access: yesArquivos de Neuro-Psiquiatria, 1999
AIMS: 1. To verify the sensibility of panic patients to a mixture of 35% CO2 and 65% O2. 2. To determine if a ten days treatment with clonazepam attenuates the panic attacks induced by the inhalation of 35% carbon dioxide in panic disorder.
ANTONIO EGIDIO NARDI   +3 more
doaj  

Effect of nobiletin on experimental model of epilepsy

open access: yesTranslational Neuroscience, 2018
The effects of nobiletin, a plant-derived flavonoid was examined against pentylenetetrazole (PTZ)-induced seizures. The study also aimed to assess whether nobiletin potentiated the effects of antiepileptic drug clonazepam (CZP).
Yang Baowang, Wang Jing, Zhang Ni
doaj   +1 more source

In silico prediction of novel effective combinational treatment of chronic pain in individual patients: A joint white paper of the H2020 QSPainRelief consortium

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Opioids are prescribed widely for chronic pain despite well‐recognised risks and variable long‐term benefit, reflecting the lack of effective alternatives for many patients. Combination therapies offer a promising strategy to enhance efficacy whilst reducing side effects.
André Mouraux   +26 more
wiley   +1 more source

Deprescribing clonazepam in primary care older patients : a feasibility study

open access: yes, 2022
: Background Inappropriate use of clonazepam by older adults is associated with cognitive impairment, delirium, and falls. Strategies to optimize its use are important to increase patient safety.
Blatt, Carine Raquel   +8 more
core  

Home - About - Disclaimer - Privacy